Quantitative Systematic Strategies LLC Chimerix Inc Transaction History

Quantitative Systematic Strategies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$1.3 - $2.72 $17,782 - $37,206	-13,679 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$1.93 - $4.21 $3,599 - $7,851	-1,865 Reduced 12.0%	13,679 $32,000
Q2 2019 Jul 25, 2019	BUY	$2.05 - $4.32 $31,865 - $67,150	15,544 New	15,544 $67,000
Q1 2019 Apr 15, 2019	SELL	$1.79 - $3.12 $39,202 - $68,331	-21,901 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$2.24 - $3.9 $49,058 - $85,413	21,901 New	21,901 $56,000
Q2 2018 Aug 07, 2018	SELL	$4.43 - $5.14 $98,301 - $114,056	-22,190 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$4.65 - $5.9 $103,183 - $130,921	22,190 New	22,190 $115,000
Q4 2017 Feb 01, 2018	SELL	$4.32 - $5.52 $86,771 - $110,874	-20,086 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$4.35 - $5.25 $87,374 - $105,451	20,086	20,086 $105,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $88.5M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.